Ticker: PCSA

Company: Processa Pharmaceuticals, Inc.

Person: Geraldine Pannu, director

Transaction date: March 31, 2026

Reporting date: April 1, 2026

Average share price: 2.535

Bought 2072.0 shares for 5252.52